$SIGA

SIGA TECHNOLOGIES INC (SIGA): Results of Operations and Financial Condition

SIGA TECHNOLOGIES INC (SIGA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026 • $37 Million of TPOXX Sales Generated in the Second Quarter • Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, August 6, 2026 (GLOBENEWSWIRE) -- SIGA Technologies, Inc. (SIGA)

Original reporting
Published Aug 6, 2026, 8:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SIGA
Neutral
medium confidence
Mentioned
$SIGA
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SIGANeutralMed
01

Why it matters

The disclosure centers on TPOXX sales/deliveries and the statement that Q2 deliveries completed the last procurement order under the 19C contract, which can affect expectations for near-term revenue run-rate and the need for new U.S. and international procurement.

02

Market read

This is a company-specific earnings-style update with concrete TPOXX delivery numbers and a key contract milestone (19C order completion), alongside YoY declines in product sales and total revenues.

03

What to watch

Traders may be underweighting the mix shift between IV and oral formulations and the role of R&D revenues in total revenue trends, since operating income margin changes are attributed to product mix.

Relevance 7/10Novelty 6/10Timing: after-hours SEC 8-K filed Aug 6, 2026, with conference call at 4:30 PM ET

Background

SIGA filed an SEC Form 8-K with Exhibit 99.1 reporting financial results for the three and six months ended June 30, 2026, plus a corporate update call.

Company-level read

Ticker impact

$SIGANeutralMedium confidence
Context

SIGA reported Q2 and 6M ended June 30, 2026 results, including $37 million of TPOXX sales and completion of the last 19C procurement order.

Expected impact

Near-term volatility possible as traders reprice the durability of TPOXX demand after 19C order completion and the YoY revenue decline.

Evidence & confidence

The filing provides concrete quarterly delivery figures ($37M total; $24M IV to U.S. stockpile; $13M oral internationally) and shows product sales and total revenues down versus 2025, but it does not provide new guidance or a new contract award.

Market effects

Biodefense/pharma counters may see read-across on government stockpile procurement cadence and international commercialization progress for smallpox countermeasures.

U.S. stockpile delivery completion may shift attention to U.S. BARDA procurement timing and Europe/Asia commercialization execution.

International TPOXX deliveries highlight cross-region demand, but the article does not quantify new global contract wins.

Counterpoint

The 19C procurement order completion could be a temporary step-down, while the company’s multi-formulation, multi-region delivery model may still support future contract replenishment.

Key entities

  • SIGA Technologies, Inc.

    Commercial-stage pharmaceutical company reporting Q2 and 6M 2026 results and TPOXX delivery activity.

  • TPOXX

    SIGA’s smallpox countermeasure referenced in delivery and sales figures.

  • 19C contract

    U.S. procurement contract under which the last procurement order was completed via Q2 deliveries.

  • BARDA

    U.S. Biomedical Advanced Research and Development Authority referenced in forward-looking risk language.

Related articles

$SIGAMed

SIGA (SIGA) Q2 2026 Earnings Call Transcript

SIGA Technologies reported Q2 2026 results in an earnings call. Total revenue fell to $41.0M from $81.1M due to delivery timing. Operating income was $13.9M and net income $12.5M, with diluted EPS $0.17. Cash was $117.6M, zero debt. Management said the final IV TPOXX order under the 19C contract was completed and a new U.S. contract is targeted after slower HHS transitions.

$SIGAMedAI 8/10

Sigma Advanced Systems Secures USD 104.9 Million Export Order for Next-generation Extended Range 155mm Base Bleed Artillery Shells

Sigma Advanced Systems said it won a USD 104.9 million export order from a North American customer to manufacture and supply 147,000 units of 155mm base bleed artillery shell bodies over the next 6 to 12 months. The company cited prior contracts for 155mm fuzes and M107 shell bodies and said the shells reduce drag to extend range. Sigma shares last traded at Rs. 521.45 on BSE.

$TGTHighAI 8/10

Target's Non-Merchandise Sales Jump 20% as New Revenue Streams Scale

Target Corporation reported a 5.3% year-over-year increase in total net sales to $26.54 billion for Q2 2026, with non-merchandise sales surging 20.1%. Growth was driven by Roundel advertising, Target Circle 360 memberships, and Target+ marketplace. Advertising revenues rose to $279 million, while other revenues increased to $174 million. The company's shares have risen 32.7% over the past three months, outperforming industry peers.

$DELLHighAI 9/10

Evercore ISI Names Top Pick, Lifts Target to $575 on AI Growth

Evercore ISI kept Dell Technologies as a Top Pick with an Outperform rating and a $575 price target, despite removing it from its Tactical Outperform list. Dell reported July-quarter sales of $47B and EPS of $7.04, beating estimates. Revenue grew 58% YoY, driven by AI and traditional server demand. Dell raised FY27 revenue guidance to $192B and EPS to $25.50. Evercore ISI cited supply constraints as supportive of sustained growth.

$NVDAHighAI 8/10

Nvidia just sent a strong signal to AMD and Intel investors

Nvidia reported Q2 2027 revenue of $96.2B, up 106% YoY, with data center revenue at $89B, up 117%. Its server CPU business, including Grace and Vera, is growing rapidly, with $5B in trailing 12-month revenue. Nvidia expects $20B in server CPU demand this fiscal year and projects CPU revenue to double in fiscal 2028. AMD and Intel, with market shares of 34.5% and 65.5% respectively, face competition from Nvidia's integrated server solutions.